Brain Trauma Blueprint Action Summit
October 18-19, 2022 – Washington, D.C.
2022 Brain Trauma Blueprint Action Summit Highlights
Announcing the Brain Trauma Blueprint Action Coalition
CVB’s CEO & President Magali Haas, MD, PhD announced the development of the Brain Trauma Blueprint Action Coalition, a public-private partnership alliance optimizing the capabilities of industry, academia, government, and other stakeholders to take action on the TBI Roadmap recommendations.
The coalition will support and advance a coordinated approach to accelerate the development and adoption of new solutions for TBI. Initial Brain Trauma Blueprint Action Coalition members include the Brain Trauma Foundation, 22 Jumps, and the David R. Metcalf Invisible Wounds Foundation.
Watch Highlights from the Action Summit
About the Brain Trauma Blueprint Action Summit
The inaugural Brain Trauma Blueprint (BTB) Action Summit was held on October 18-19th 2022 at the Ronald Reagan Building and International Trade Center in Washington DC. This event convened national stakeholder groups across government, academia, foundations, industry, and individuals with lived experience, to plan to execute the TBI Precision Research Roadmap, through collective public and private action.
Every year, millions of Americans, including Veterans, active military, first responders and public safety personnel, experience traumatic brain injuries and their devastating chronic effects, including suicide. Yet, in 2022, we still have no FDA-approved TBI diagnostics or treatments.
Through prior BTB State-of-the-Science Summits we worked with the research community to identify and publish consensus challenges and a path ahead. The resulting TBI Precision Research Roadmap maps out priorities for accelerating a first generation of precision diagnostics and targeted treatments for brain trauma.
During the inaugural Action Summit, the TBI leadership community discussed priorities and a path to foster collaboration across the broader stakeholder community to achieve solutions sooner for those suffering from trauma-related brain disorders.